Author:
Scandolara Thalita Basso,Pacholak Leticia Madureira,Tavares Isabella Morais,Kern Rodrigo,Garcia-Velazquez Leonardo,Panis Carolina
Reference194 articles.
1. N. Am, N. Howlader, M. Krapcho, D. Miller, A. Brest, M. Yu, J. Ruhl, Z. Tatalovich, A. Mariotto, D.R. Lewis, H.S. Chen, E.J. Feuer, K.A. Cronin, SEER Cancer Statistics Review, 1975–2015, Bethesda, MD, 2018.
2. Use of immune checkpoint inhibitors in the treatment of patients with cancer and preexisting autoimmune disease;Abdel-Wahab;Ann. Intern. Med.,2018
3. Molecular pathways: targeting the stimulator of interferon genes (STING) in the immunotherapy of cancer;Corrales;Clin. Cancer Res.,2015
4. The future of immunotherapy: a 20-year perspective;Wraith;Front. Immunol.,2017
5. Improved mouse models to assess tumour immunity and irAEs after combination cancer immunotherapies;Liu;Clin. Transl. Immunol.,2014